ABSTRACT Cesium uptake by sodium-loaded frog sartorius muscles was inhibited 100 % by 10 --8 u ouabain and 10 -6 M cymarin. The doses for 50 % inhibition of cesium uptake by five cardiotonie aglycones were 1.5 X 10-7 M for strophanthidin, 2 X 10 -~ M for telocinobufagin, 1.6 X 10-e M for digitoxigenin, 2.4 X 10 -6 M for periplogenin, and 6.3 X 10-e M for uzarigenin. Because of the limited solubility of sarmentogenin the maximum concentration studied was 2 X 10 -6 M which inhibited cesium uptake about 36 %. Inhibition of cesium uptake by cymarin was not reversed during a 3.5 hr incubation in fresh solution while the muscles treated with ouabain and strophanthidin recovered partly during this time. Cymarin was a more potent inhibitor of sodium efflux than strophanthidin and periplogenin was less potent. Increased cesium ion concentration in the external solution decreased the strophanthidin inhibition of cesium uptake but 25 mM cesium did not overcome the inhibition by 10-s-10 -6 M strophanthidin. Increased potassium ion concentration in the external solution decreased but did not completely overcome inhibition of sodium efltux by strophanthidin. It is concluded that potassium or cesium ions do not compete with these drugs for a particular site on the ion transport complex. The same structural features of the drugs are necessary for inhibition of ion transport in frog muscle as are required for inhibition of ion transport in other tissues, inhibition of sodium-potassium-stimulated ATPases, and toxicity to animals.
ABSTRACT Cesium uptake by sodium-loaded frog sartorius muscles was inhibited 100 % by 10 --8 u ouabain and 10 -6 M cymarin. The doses for 50 % inhibition of cesium uptake by five cardiotonie aglycones were 1.5 X 10-7 M for strophanthidin, 2 X 10 -~ M for telocinobufagin, 1.6 X 10-e M for digitoxigenin, 2.4 X 10 -6 M for periplogenin, and 6.3 X 10-e M for uzarigenin. Because of the limited solubility of sarmentogenin the maximum concentration studied was 2 X 10 -6 M which inhibited cesium uptake about 36 %. Inhibition of cesium uptake by cymarin was not reversed during a 3.5 hr incubation in fresh solution while the muscles treated with ouabain and strophanthidin recovered partly during this time. Cymarin was a more potent inhibitor of sodium efflux than strophanthidin and periplogenin was less potent. Increased cesium ion concentration in the external solution decreased the strophanthidin inhibition of cesium uptake but 25 mM cesium did not overcome the inhibition by 10-s-10 -6 M strophanthidin. Increased potassium ion concentration in the external solution decreased but did not completely overcome inhibition of sodium efltux by strophanthidin. It is concluded that potassium or cesium ions do not compete with these drugs for a particular site on the ion transport complex. The same structural features of the drugs are necessary for inhibition of ion transport in frog muscle as are required for inhibition of ion transport in other tissues, inhibition of sodium-potassium-stimulated ATPases, and toxicity to animals.
I N T R O D U C T I O N
Muscles enriched with sodium will take up cesium ions from the external solution and extrude sodium ions (Beaugd and Sjodin, 1968) . Although the mechanism of this ion movement is unknown, both the cesium uptake and part of the sodium efflux are sensitive to the cardiotonic steroids such as ouabain and strophanthidin (Sjodin and Beaug6, 1967; Beaugd and Sjodin, 1968) . As most studies of ion transport in frog muscle have used only high concentrations of these drugs, 10 -5 M, tO inhibit the ion fluxes it is of interest to determine the effects of lower dosages of these drugs. Also, certain structural requirements for the drugs have been determined by measuring inhibition of ion transport by the drug in red blood cells and the lethal dosage in cats for a variety of these drugs (Kahn and Acheson, 1955; Kahn, 1957; Glynn, 1957; Machova, 1961; Chen, 1963; Tamm, 1963) . Machova found a direct relationship between the mean lethal dosage in eats and the concentration required for 50% inhibition of potassium ion uptake in red blood cells. The ability of several active cardiac drugs to inhibit ion transport in frog muscles is compared in this work.
Several structural requirements found to be important for the activity of the drugs in other systems are (a) that the rings of the cyclopentanophenanthrene nucleus are joined A/B-cis, B/C-trans, and C/D-c/s; (b) that there is a hydroxyl group/3 at C-14 and either a hydroxyl group or a glycosidic link/3 at THE JOURNAL OF GENERAL PHYSIOLOGY " VOLUME 54 " I969 C-3; and (c) that the a, E-unsaturated five-membered lactone or a hexadienolide ring is joined/3 at C-17. Fig. 1 shows the basic, structure of the drugs with their numbering system. The cardiac drugs are shaped differently from the other common hormones such as the adrenal and sex hormones. In the cardiac drugs the ds fusion of rings A/B and C/D gives the drugs a very bent configuration while the other hormones have all their rings fused trans (Fig. 2) . The crystal structure of the simplest of the cardiac drugs, digitoxigenin, has just been determined and illustrates clearly this bent configuration of the molcule.1 In the cardiac drugs the 3,fl-hydroxyl group and 1-/3 and 5-/3 groups are axial z Karle, I. L., andJ. Karle. 1969. The crystal structure of digitoxigenin, C~sHuO4 • Acta Cryst., Sect. B.
In press. with respect to their rings. The five-membered lactone ring of the cardenolide is fi at C-17 and the plane of the lactone is almost perpendicular to that of the D ring of the steroid. I The hexadienolide ring, a six-membered unsaturated lactone, is attached/3 to C-17 in the bufadienolides such as telocinobafagin.
The cardenolides are more active as monosides of the C-3 hydroxyl group than are the free genins or oligosaccharides. The bufadienolides are more active as the aglycones. Several other molecular characteristics have been found to increase or decrease the activity ot the drugs but the pertinent ones will be mentioned while discussing the drugs used in this research. These drugs are listed in Table I and Fig. 3 . A similarity in the structural requirements of the drugs for inhibition of transport in different systems and inhibition of the sodium-potassium-stimulated transport adenosine triphosphatase (ATPase) would indicate that these transport systems were similar (Skou, 1965) .
METHODS AND MATERIALS
Preparation of Muscles Sartorius muscles from freshly killed frogs, Rana pipiens,
were carefully dissected and mounted as described by Sjodin and Henderson (1964) . Summer frog muscles (April to October) were enriched with sodium by storage for 16-20 hr at 4-5°C in a potassium-free Ringer solution. Winter muscles were enriched similarly for 24 hr with only one muscle per 5 ml Ringer solution, then switched to fresh potassium-free Ringer solution and stored in the cold another 16-20 hr with two muscles per 5 ml. The potassium-free Ringer solution for winter muscles contained 5 mg streptomycin per liter to reduce bacterial contamination. In the sodium effiux experiments high specific activity ~Na (50-100 ~1 of a 1 mc/ml ~NaCI solution) was added to the muscles during the last 20 hr of cold storage. These methods were adapted from Carey and Conway (1954), Henderson (1964), and Beaug6 and Sjodin (1968) . As cesium uptake and sodium efflux depend on the internal concentration of sodium, all muscles were enriched with sodium in order to have them in an approximately equal condition (Beaug6 and Sjodin, 1968; Sjodin and Beaug6, 1968) . The dependence of the strophanthidin-sensitive sodium efttux on internal sodium concentration is not so steep for high sodium muscles as it is for fresh or only slightly sodium-enriched muscles (Sjodin and Beaug6, 1968) .
Materials
The basic Ringer solutions are described in Table II Basel, Switzerland) . All drugs were prepared as 20 mM and 2 m~ solutions in ethanol and stored in the cold until used. Uzarigenin and sarmentogenin were not completely soluble at 20 mM. These solutions were allowed to settle and 50 #1 aliquots of the saturated solutions were used per 100 ml Ringer solution. The concentrations of all the drugs, exceps telocino-54 " I969 bufagin, were determined by their absorbance at 220 n m for solutions of 10--5-10 -6 M.
T h e molecular extinction coefficient, ~, for m a n y cardiac glycosides and genins is similar, being about 1.6 X 104 for strophanthidin in water (Parsons, 1965; Dorfman, 1953) .
Procedure for Cesium Uptake T h e procedure for measuring cesium uptake with mCs as a tracer was the same as described by Beaug6 a n d Sjodin (1968) . Cesium uptake was used rather than that of potassium or r u b i d i u m because cesium uptake is the most sensitive to the action of strophanthidin (Beauge and Sjodin, 1968) . After control uptake rates h a d been established (2-2.5 hr), the muscles were placed in a similar
* pH adjusted to 7.2-7.3 with HC1. All solutions contained 2 mu CaC12.
Ringer solution which contained the drug being tested. T h e rates of cesium uptake are linear for at least 20 hr in the absence of a drug (Beaug6 a n d Sjodin, 1968) . T h e control solutions contained amounts of ethanol equal to those in the d r u g solution. Except in two experiments with 10 ~ M drug, the most ethanol used was 5 0 / A per I00 ml R i n g e r solution, about 8 n~. This concentration had no effect on uptake. Ethanol does inhibit a brain sodium-potassium-stimulated A T P a s e but only about 10-20 % at 100 mM (Israel and Salazar, 1967) . Since the experiments with 10 -4 u drug contained a b o u t 80 m u ethanol it is possible that the rates were inhibited 10 % but control muscles were placed in an equal a m o u n t of ethanol so that the comparative inhibition was due to the drug. I n h i b i t e d uptake was followed for 2.5 hr. T h e estimation of extracellular space and cation analysis followed the methods of Beaug6 and Sjodin (1968) and Sjodin and Henderson (1964) . I n the experiments comparing the effects of increasing cesium concentration on strophanthidin inhibition, R i n g e r solutions F, G, H, and I were used, a n d the a m o u n t of isotope a d d e d to the uptake solutions was increased.
Procedures for Sodium Effiux
The method for sodium efflux has been described by Sjodin and Henderson (1964) . For the first hour efflux for both muscles was followed into potassium-free Ringer solution (J or in some cases L); then one muscle was tested in a potassium plus drug-Ringer solution and the control muscle in a similar solution without drug. The cation analysis was by the same method used for cesium uptake. Some experiments were done with cesium slution (I) instead of potassium solution to stimulate the sodium efflux.
R E S U L T S
Inhibition of Cesium Uptake 4. Uptake from 2.5 rn~ Cs Ringer solution was followed for 2.5 hr. Both muscles were changed to a similar solution containing 10 -6 M strophanthidin a n d uptake measured for 2.5 hr. T h e numbers in parentheses are the uptake rates in micromoles per gram wet weight per hour. after 9.5 hr control uptake. Similar experiments were done at other concentrations in order to determine the dose-activity curve for strophanthidin (Fig.  5 a) . Although there is a slight increase in activity at 10 -1° M this is probably not significant as 10 -11 and 10 -12 M had no effect. The average internal sodium concentration for the summer muscles was 93.3 ± 0.8 ~moles/g wet weight. Winter muscles revealed a slightly different sensitivity towards strophanthidin. W h e n the cold storage time was increased to about 40 hr in potassium-free solution, the internal sodium concentration was raised and this resulted in the drug sensitivity being similar to that of summer muscles. Table I I I shows the average internal sodium concentrations from a number of experiments. The half-inhibition of cesium uptake for summer muscles or very high sodium winter muscles occurred with 1.5-2 X 10 -7 M strophanthidin.
A comparison of the activity of strophanthidin, cymarin, ouabain, and sarmentogenin is shown in Fig. 5 b. Cymarin has a steroid structure similar to that of strophanthidin except that it has a D-cymarose in a glycosidic link to the 3-~-hydroxyl group. In ouabain the sugar is L-rhamnose which is also linked to the 3-~-hydroxyl group. Ouabain has 1-~-and 11-a-hydroxyl groups not found in cymarin. Also the C-19 group is an alcohol rather than a carbonyl. The testing of sarmentogenin to determine whether the 11-a-hydroxyl group FmuRs 5 a. The points are average inhibitions of cesium uptake by strophanthidin. The summer muscles were stored 16-20 hr in potassium-free Ringer solutions at 5°C while the winter muscles were similarly treated for about 40 hr. Uptake was measured from a 9.5 ram cesium solution. In this and other figures, bars represent SE. b. The muscles were stored 40 hr at 5°C in K-free Ringer solution. Each point is the average uptake by two muscles except 10 -~ M strophanthidin which is averaged from four muscles, c. Inhibition of cesium uptake from 2.5 mM cesium Ringer solution was measured with winter muscles stored 40 hr at 5°C in a K-free Ringer solution. Each point is the average of two muscles, d. A comparison of the inhibition of cesium uptake from 2.5 mM Cs Ringer solution by the ds-A/B configuration, digitoxigenin, and the trans-A/B form, uzarigenin. Each point is the average from two winter muscles stored 40 hr in K-free Ringer solution at 5°C. is the major reason for the increased activity of ouabain seems to indicate that it is not an important change. Sarmentogenin is also lacking the 5-fl-hydroxyl group and either an alcoholic or carbonyl group at C-19 which may account for its lower activity and solubility. Fig. 5 c compares periplogenin and telocinobufagin. In these two drugs the steroid is the same except t h a t in telocinobufagin there is a six-membered unsaturated lactone ring. Telocinobufagin is 15 to 20 times more active t h a n periplogenin, with a five-membered lactone, and about as active as strophan- thidin. T h e difference between the isomers, digitoxigenin-uzarigenin, is that the A / B rings are joined trans rather t h a n cis in uzarigenin making the molecule more open t h a n digitoxigenin (Fig. 6 ). This change results in a slight loss in activity for uzarigenin (Fig. 5 d) . Digitoxigenin, periplogenin, and uzarigenin are less active t h a n strophanthidin. Periplogenin has only a C-19 methyl group rather t h a n a carbonyl group and is 10 times less active. Digitoxigenin is lacking both the 5-/3-hydroxyl group and C-19 carbonyl group but is slightly more active t h a n periplogenin.
Recovery from Inhibition
T h e reversibility of inhibition by cymarin, ouabain, and strophanthidin was compared because cymarin and ouabain were more active than strophanthidin. In the experiments summarized in T a b l e I V control uptake was followed
T A B L E IV R E V E R S I B I L I T Y OF D R U G I N H I B I T I O N
T h e rates for each drug t r e a t m e n t averaged from four winter muscles stored 40 hr at 5°C in K-free Ringer solution. T h e recovered rate is to be compared with the initial rate measured on the same muscle. All rates are q-sE. FmuR~ 7. Cesium uptake in the presence and absence of strophanthidin was measured in various cesium Ringer solutions. Uptake was measured for 2.5 hr for the control rates and inhibited rates. The summer muscles were stored 20 hr at 5°C in K-free Ringer solution. The control points are averages of six muscles except for 15 m_M Cs which is from three muscles. The other points are averages of two muscles except 15 mM points which are from one muscle.
for 2-2.5 hr, inhibited uptake for another 2 hr, and recovery for 3.5 hr. A longer recovery time, 5-8 hr, would have allowed the strophanthidin-treated muscles to recover completely (Beaug~ and Sjodin, 1968) . In this comparison the strophanthidin-treated muscles recovered to about 50% of their initial rates, ouabain-treated ones to 25o-/0 of their initial rates, and cymarin-treated ones not at all. Since cymarin and ouabain are about equally potent inhibitors of cesium uptake, their different behavior here might be due to the different sugars.
Effect of Raising the External Cesium Concentration
A series of experiments measuring the inhibition of cesium uptake by strophanthidin at different external cesium concentrations is shown in Fig. 7 . As the cesium concentration was raised there was some reduction in the inhibition, but Table V shows that the per cent inhibition with 10 -6 M was about 800-/o at all cesium concentrations. Even at the lower drug concentrations the inhibition was not removed by 25 mM cesium.
Inhibition of Sodium Efftux
T h e ability of the drugs to inhibit sodium efflux was compared using sodiumrich muscles labeled with ~2Na ( Fig. 8) . muscles into potassium-free Ringer solution (J) was followed for 1 hr. Then efflux from one muscle was followed in 2.5 rnM potassium Ringer solution (A) and compared with effiux from the other muscle into a similar solution containing 10 -7 M strophanthidin. In this case there was a 25% inhibition of the potassium-stimulated efflux. A concentration of 10 -5 M strophanthidin blocked all the potassium-stimulated sodium efflux. A dose-activity curve for strophanthidin inhibition of sodium efflux was prepared. T h e curve in Fig. 9 was steeper than that for cesium uptake, going from 100% inhibition at 10 -s M to 0 % at 10 -s M strophanthidin. In order to use cesium to stimulate the sodium p u m p the cesium concentration was raised to 25 rnM and consequently the external sodium concentration was lowered to 80 rnM for an osmotically balanced solution. To insure that lowered sodium concentration did not affect the sensitivity, the inhibition produced by strophanthidin was measured with only 80 mM sodium outside (solutions L and D). T h e per cent inhibitions were not significandy different even though the absolute rates were somewhat higher in the lower sodium solutions. for c o m p a r i s o n are the same drugs' inhibition of cesium uptake. T h e drugs fall into the same relative order for inhibition of sodium effiux or cesium uptake. T a b l e V I I c o m p a r e s the inhibitions of b o t h assays b y 10 -6 a n d 10 -7 M s t r o p h a n t h i d i n in 25 m_M cesium R i n g e r solution. E a c h experimental point was the average of two experiments. As was seen in the dose-activity curve for strophanthidin the sensitivity curve for sodium effiux inhibition w a s steeper than that for cesium uptake. T h e higher concentration, 10 -6 ra, inhibited sodium efflux more than cesium uptake while 10 -7 M inhibited the effiux less than the uptake. 
In this experiment efflux from a pair of T A B L E V P E R C E N T I N H I B I T I O N O F C E S I U M U P T A K E BY S T R O P H A N T H I D I N * C o n c e n t r a t i o n of s t r o p h a n t h i d i n Per cent i n h i b i t i o n E x t e r n a l cesium
T A B L E V I C O M P A R I S O N B E T W E E N T H E ABILITY O F V A R I O U S D R U G S T O INHIBIT SODIU]V[ E F F L U X A N D C E S I U M U P T A K E Drug
Effect of Increasing External Potassium Concentration
The inhibition of sodium efflux at three outside potassium concentrations was measured to determine whether potassium ion competes with the drug for the enzyme site. Fig. 10 compares the rates of sodium efflux, not corrected for the potassium-free efflux rates, in the various potassium Ringer solutions. O n e can see that at low potassium concentrations, 10 -5 and 10 -e M strophanthidin reduced the sodium efflux to rates lower than those found in potassium-free ,',80
solutions. The lowest concentration tested, l0 -s M, is not shown as it was not significantly different from the control. The other concentrations show inhibition at all potassium concentrations. Although some interaction was observed the results do not indicate competitive inhibition. The presence of a large potassium-free sodium effux and the fact that high concentrations of the drug can inhibit some of this effux, make the mechanism of transport more difficult to interpret. FIGURe. 10. Total sodium efflux was measured into potassium Ringer solutions with strophanthidin. The potassium-free rate is from 68 muscles while the other drug-treated rates are averages from 2 pairs. The control curve is an average of 16 pairs for 2.5 mM K, 10 for 7.5 mM K, and 8 for 12 mM K solutions.
D I S C U S S I O N
Several slightly different cardiac drugs were used in these experiments in the hope that a knowledge of the structural requirements for drug activity might help to identify the nature of the drug-sensitive site on the membrane. This work examined several structural modifications of the drugs with respect to inhibition of ion transport in frog muscle. The trans-A/B form, uzarigenin, showed reduced activity compared with the cis-A/B isomer, digitoxigenin; the doses for 50o-/0 inhibition being 6.3 X 10 -6 M for uzarigenin and 1.6 X 10 -6 u for digitoxigenin. The lethal dosage in cats for uzarigenin is about twice that needed for digitoxigenin (Tamm, 1963) . Kupchan and coworkers (1967) compared several cardiac steroids for their cytotoxic activity and ATPase inhibition. In both assays activity of the drug was reduced with the change from cis-A/B to trans-A/B. In frog muscle the bufadienolide, telocinobufagin, was a more potent inhibitor of transport than the similar cardenolide, periplogenin. Telocinobufagin was also found to be four times more potent for inhibiting transport in red blood cells than periplogenin (Kahn, 1957) . Another bufagin, hellebrigenin, has been found to be more active against a sodium-potassium ATPase than its cardenolide isomer, strophanthidin (Ruoho et al., 1968) . However, compounds with saturated lactones were always less potent inhibitors of transport than their corresponding glycosides with unsaturated lactones and often less potent than the free genins of the same compounds (Kahn, 1957) . Another variation examined was the C-19 methyl group compared with the C-19 aldehyde or hydroxymethyl groups. The C-19 aldehyde group resulted in a more potent compound than one with a C-19 methyl group as seen in the comparison of activity of strophanthidin and periplogenin. The same relationship was found for lethal dosages in cats (Chen, 1963; Tamm, 1963) . A C-19 hydroxymethyl group as on ouabain results in a more active compound than one with the methyl group.
The importance of the 5-~-hydroxyl group and of the glycosidic sugars was examined. The 5-~-hydroxyl groups in strophanthidin, cymarin, periplogenin, and telocinobufagin result in increased potency for these drugs (Chen, 1963) . Although 11-a-hydroxyl groups can give increased activity to the compound, the lack of oxygen-containing groups at C-19 and C-5 in sarmentogenin results in a weaker compound. In the cardenolides the monosides are usually the most active (Tamm, 1963; Chen, 1963) . Cymarin and ouabain show this characteristic when cymarin is compared with strophanthidin. The presence of the cymarose gives cymarin increased activity especially at lower concentrations. Cymarin behaves much like ouabain which also is a monoside with rhamnose. Muscles treated with the glycosides, ouabain and cymarin, remained inhibited longer than the ones treated with the free genin, strophanthidin, when they were resuspended in drug-free control solutions. A comparison of the inhibition of sodium efflux by strophanthidin, cymarin, and periplogenin with their inhibition of cesium uptake revealed no large differences in their relative activities in both assays.
The results of the structural comparisons show the same structure-activity relationships which have been found in other systems such as red blood cell sodium-potassium transport. The most important area of the drug appears to be the unsaturated lactone and its E-link to C-17 of the D ring of the steroid. Sugars at the C-3 position also increase the toxicity of the drugs but other changes, especially at C-19, are not as important.
Although the concentrations of the drugs were measured in solutions of 10 -6-10 -5 M before an experiment, no attempt was made to devise a system for determining lower concentrations of the drugs, or to measure the concentration remaining in the solution after an experiment. Such measurements of the drug concentrations after an experiment might indicate that one reason for lower activitiy of a drug was that this drug was less well-absorbed by the muscle than the other drugs. Also, from the concentration of drug taken up by the muscle one might estimate how many active or drug-sensitive sites were on the muscle. However, since the whole sartorius muscle was used rather than a single fibril and because the extraceUular space of the muscle is large, 220-/0,
the estimate would not be very reliable. There also appears to be a certain amount of unspecific binding of these drugs which would increase the error in any estimate of the number of drug-sensitive sites (Kupchan et al., 1967) . The early work by Glynn (1957) implied that scillaren A inhibition could be removed by increasing the potassium concentration. More recent experiments have shown that potassium does not compete with the drugs for sites. In fact, the amount of inhibition obtained depends on both the external potassium concentration and the internal and external sodium concentrations with external sodium ion increasing the observed inhibition by the drugs (Whittam and Ager, 1962; Repke and Portius, 1963; Kinsolving, Post, and Beaver, 1963; Schatzmann, 1963 Schatzmann, , 1965 Auditore, 1964 Auditore, , 1965 Baker and Connelly, 1966) . Matsui and Schwartz (1966) have examined the competition between potassium ions and the drugs on a cardiac sodium-potassium-dependent ATPase. They found that the interaction was noncompetitive and depended on the sodium to potassium ratio in the solution. At a constant sodium concentration, the per cent inhibition of the ATPase by ouabain decreased with increasing potassium concentration while conversely, at a constant potassium concentration the per cent inhibition increased with increasing sodium concentration. The resulting kinetics were difficult to determine because the sodium and potassium ions are competitive inhibitors of their respective activating sites. In their experiments when the ratio of sodium to potassium in the medium was kept constant at l0 to 1 the double reciprocal plots, rate-' vs.
[K] -1, became linear and indicated noncompetitive inhibition. Matsui and Schwartz concluded that the ouabain-binding site was different from the potassium site.
In these experiments the interaction between the drugs and potassium ion with respect to sodium efflux indicated that potassium ion could not prevent completely inhibition by strophanthidin. The same situation was true for inhibition of cesium uptake when increased cesium concentration did not completely remove strophanthidin inhibition. This indicated that the drugs were not truly competitive with potassium ion for a site on the transport enzyme. Since there is some sort of interaction one might suppose that the attachment of potassium ion or the drug to the enzyme changes the affinity of the enzyme toward the other.
S U M M A R Y
These studies indicate that the same structural details of the cardiac drugs, as are required to inhibit sodium-potassium-stimulated ATPase in cell membranes, and to cause heart fibrillation and death in cats and other animals, are important for their ability to inhibit sodium-potassium transport across cell membranes. The comparison of several cardiac drugs with different sub-stituents o n t h e basic steroid s h o w e d t h a t t h e c i s -A / B c o n f i g u r a t i o n o f t h e d r u g was a m o r e active i n h i b i t o r of t r a n s p o r t t h a n t h e trans-configuration, a b u f a d i e n o l i d e w a s m o r e active t h a n t h e similar c a r d e n o l i d e , t h e p r e s e n c e of a C-19 a l d e h y d e o r h y d r o x y m e t h y l g r o u p resulted in a m o r e active c o m p o u n d t h a n t h e p r e s e n c e of a C -1 9 m e t h y l g r o u p , a 5 -3 -h y d r o x y l g r o u p resulted in a m o r e active c o m p o u n d t h a n o n e w i t h a 5 -3 -h y d r o g e n , a n d m o n o s i d e s o f t h e c a r d e n o l i d e s w e r e m o r e active t h a n t h e free genins. T h e m o s t i m p o r t a n t a r e a o f t h e d r u g is t h e u n s a t u r a t e d l a c t o n e a n d its/3-1ink to C-17. T h e s e d r u g s act o n t h e outside of t h e m e m b r a n e b u t n o t at t h e p o t a s s i u m site since p o t a s s i u m a n d t h e o t h e r ions d o n o t s h o w t r u e c o m p e t i t i o n w i t h t h e drugs. T h e a t t a c h m e n t o f t h e d r u g s to t h e m e m b r a n e seems to b e slowly reversible in t h e case o f the genins a n d v e r y slowly o r n o t at all reversible in t h e case o f t h e glycosides.
